Skip to main content
. 2022 Jul 29;15(8):944. doi: 10.3390/ph15080944

Figure 2.

Figure 2

Treatment of leukemia, breast, and colorectal cancer cell lines with myrrh resin extract. Cell viability was assessed by TiterGlo™ assay, and serial dilution was used to calculate the IC50 values. The X-axis presents the log of myrrh concentration in µg/mL, and the Y-axis presents normalized absorbance as a percentage.